Meeting
2015 ASCO Annual Meeting
Serum tumor marker utilization in patients with advanced solid tumors.
Authors
Melissa Kate Accordino
New York Presbyterian Columbia, New York, NY
Melissa Kate Accordino , Jason Dennis Wright , Sowmya Vasan , Alfred I. Neugut , Ana Isabel Tergas , Dawn L. Hershman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality of Care
Track
Health Services Research and Quality of Care
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 33, 2015 (suppl; abstr 6599)
DOI
10.1200/jco.2015.33.15_suppl.6599
Abstract #
6599
Poster Bd #
156
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Utility of tumor marker levels in predicting survival of patients with appendiceal adenocarcinoma.
First Author: Abdelrahman M.G. Yousef
Poster
2015 Gastrointestinal Cancers Symposium
S100P tumor-marker response to chemotherapy in patients with advanced pancreatic cancer.
First Author: Shuichi Mitsunaga
Poster
2013 Genitourinary Cancers Symposium
Pre-cystectomy serum levels of CA19-9, CA125, and CEA: Correlation with pathologic stage and oncologic outcome in urothelial carcinoma of bladder.
First Author: Hamed Ahmadi
Poster
2023 ASCO Annual Meeting
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases.
First Author: Mark Charles Korpics